Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista vs Azep vs Flixonase in Chinese patients with Allergic Rhinitis
NCT03599791Phase 3Completed
- Sponsor
- Meda
- Start
- Jun 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine + fluticasone in allergic rhinitis (AR), sponsored by Meda. Started Jun 2018; status: completed.
02
Drugs
azelastine + fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03599791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599791.